GLOW & KLOW: evaluating blend evidence

A product name is not a standard formula

GLOW and KLOW are product names rather than standardised scientific formulations. Interpretation requires the constituent list, nominal amount of each constituent, exact identity of any TB-500 material and analysis of the combined preparation. Do not assume two suppliers use identical formulations.

Component evidence has a limited scope

Individual BPC-157, GHK-Cu and thymosin-related papers cannot establish the composition, compatibility, stability or biological behaviour of a named blend. The publications below are component context only, not studies of GLOW, KLOW or ECL preparations.

Read the report constituent by constituent

Check which analytes were identified and measured, the method, sample description and supplier batch field. Preserve each measured value. A missing purity result should stay missing; measured component content is not an overall purity percentage.

What remains to be established

The sources reviewed do not establish synergistic effects or validate a combined preparation. Confirm the formulation for the selected size and ask for the applicable document before relying on a blend specification.

Component research only

• Chang et al. (2011), BPC-157 in tendon models.
• Maquart et al. (1988), GHK-Cu in fibroblast cultures.
• Esposito et al. (2012), analytical identification of a TB-500 fragment.